Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Accumulated Expenses (2010 - 2026)

Exelixis (EXEL) posted quarterly Accumulated Expenses of $87.5 million for Q2 2026, down 2.49% year-over-year from $89.7 million in Q2 2025, and down 14.39% quarter-over-quarter from $102.2 million in Q1 2026.

Analysis

Exelixis (EXEL) Accumulated Expenses (2010 - 2026) Analysis & Trends

Exelixis' Accumulated Expenses history runs 17 years deep, the most recent figure standing at $87.5 million for Q2 2026.

  • In Q2 2026, Accumulated Expenses fell 2.49% year-over-year to $87.5 million; the TTM figure through Apr 2026 stood at $87.5 million (down 2.49% YoY), while the FY2026 annual figure was $102.2 million, down 6.93% from the prior year.
  • Accumulated Expenses for Q2 2026 stood at $87.5 million, down from $102.2 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $109.8 million in Q1 2025, with the low at $42.8 million in Q2 2022.
  • The 5-year median for Accumulated Expenses is $77.2 million (2022), against an average of $79.4 million.
  • The sharpest annual moves came in 2023 and 2026: Accumulated Expenses surged 32.23% in 2023, then dropped 6.93% in 2026.
  • Exelixis' Accumulated Expenses stood at $77.2 million in 2022, then increased by 20.95% to $93.3 million in 2023, then declined by 2.91% to $90.6 million in 2024, then grew by 15.19% to $104.4 million in 2025, then slipped by 16.15% to $87.5 million in 2026.
  • Business Quant data shows EXEL's Accumulated Expenses at $87.5 million in Q2 2026, $102.2 million in Q1 2026, and $104.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 68.63 Mn
Apr 3, 2026 87.51 Mn
Jan 2, 2026 102.22 Mn
Oct 3, 2025 104.36 Mn
Jul 4, 2025 72.25 Mn
Apr 4, 2025 89.75 Mn
Jan 3, 2025 109.83 Mn
Sep 27, 2024 90.61 Mn
Jun 28, 2024 71.81 Mn
Mar 29, 2024 72.96 Mn
Dec 29, 2023 93.33 Mn
Sep 29, 2023 81.40 Mn
Jun 30, 2023 68.21 Mn
Mar 31, 2023 56.55 Mn
Dec 30, 2022 77.16 Mn
Sep 30, 2022 66.93 Mn
Jul 1, 2022 61.45 Mn
Apr 1, 2022 42.77 Mn
Dec 31, 2021 61.97 Mn
Oct 1, 2021 53.31 Mn